Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors

Conditions:		Hepatitis C Virus
Purpose:		Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.
Study Summary:
Criteria:		Inclusion Criteria: - HCV infected on immunosuppression
NCT ID:		NCT00819026
Primary Contact:		Principal Investigator Robert Striker University of Wisconsin, Madison
Backup Contact:		N/A
Location Contact:		Madison, Wisconsin 53706 United States Rob Striker, MD/PhD Phone: 608-263-2994 Email: rtstriker@wisc.edu Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		May 24, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.